everything blog

Genentech said that interim data from a clinical trial showed that 1.2 percent of patients treated with a high dose of Lucentis had a stroke.

This entry was posted on Friday, January 26th, 2007 at 11:12 pm and is filed under everything. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.